Classical Hodgkin Lymphoma Overview

Save information for later
Sign Up

Learn About Classical Hodgkin Lymphoma

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Classical Hodgkin Lymphoma Local Doctors?
Nurse Practitioner
Nurse Practitioner
7500 Porter Rd, 
Niagara Falls, NY 
 (3.0 mi)
Languages Spoken:
English

Jessica Kostrewa is a Nurse Practitioner in Niagara Falls, New York. Kostrewa and is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. Her top areas of expertise are Small Lymphocytic Lymphoma (SLL), Classical Hodgkin Lymphoma, and Smoldering Multiple Myeloma.

Roswell Park Cancer Institute

Elm And Carlton St, 
Buffalo, NY 
 (14.9 mi)
Languages Spoken:
English

Francisco Hernandez-Ilizaliturri is an Oncologist in Buffalo, New York. Dr. Hernandez-Ilizaliturri and is rated as a Distinguished provider by MediFind in the treatment of Classical Hodgkin Lymphoma. His top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Aspiration, and Gastrostomy.

 
 
 
 
Learn about our expert tiers
Learn More
Internal Medicine | Hospital Medicine
Internal Medicine | Hospital Medicine

Roswell Park Cancer Institute

Elm And Carlton St, 
Buffalo, NY 
 (14.9 mi)
Languages Spoken:
English

Mamoon Bokhari is a Hospital Medicine provider in Buffalo, New York. Dr. Bokhari and is rated as an Advanced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. His top area of expertise is Classical Hodgkin Lymphoma.

What are the latest Classical Hodgkin Lymphoma Clinical Trials?
A Phase 2 Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)

Summary: The primary purpose of the study is to assess the pharmacokinetics (PK) profile of pembrolizumab following subcutaneous (SC) injection of pembrolizumab coformulated with hyaluronidase, and to evaluate the objective response rate (ORR) of pembrolizumab (+) berahyaluronidase alfa SC in adult participants with Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Randomized Phase II Study of Pembrolizumab and Brentuximab Vedotin Versus GDP, Followed by High Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed/Refractory Classical Hodgkin Lymphoma

Summary: This study is being done to determine if two new drugs can shrink or eliminate classical Hodgkins lymphoma.